# KISQALI FEMARA CO-PACK

NDC: 0078-0909
Generic name: letrozole and ribociclib
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: KIT
Routes: —
Marketing started: 20170504
Marketing ended: 20260831
FDA application: NDA209935

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0909"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0909
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa5e4446-19cd-4235-a382-5b48bf6c3b2f